no exogenous insulin supplementation???i was surprised to read this in the Echelon report.... it is not something I remember reading anywhere or that Sernova has publicly announced this fact. Has anyone read this anywhere else?
I think this would be very big news....
we are primarily focused in the near-term on patient outcomes in the University of Chicago-based clinical trial for which early patient outcomes (sustainability of blood glucose homeostasis post-Cell Pouch implantation without exogenous insulin supplementation has been observe in early cases) have been highly encouraging